Inhibition of Platelet Function by Sulbenicillin and Its Metabolite
- 1 May 1978
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 13 (5) , 881-883
- https://doi.org/10.1128/aac.13.5.881
Abstract
The effect of sulbenicillin and its major metabolite, α-sulfobenzylpenicilloic acid, on platelet function was investigated. Sulbenicillin caused inhibition of platelet aggregation and release reaction in the same manner as carbenicillin. α-Sulfobenzylpenicilloic acid was found to cause much stronger inhibition of platelet function. The results indicate that the strong inhibitory action of α-sulfobenzylpenicilloic acid may also take part in impaired platelet functions following administration of sulbenicillin to humans.This publication has 8 references indexed in Scilit:
- Effects of Cephalothin and Penicillin G on Platelet Function in VitroBritish Journal of Haematology, 1977
- Study of the Effects of Ticarcillin on Blood Coagulation and Platelet FunctionAntimicrobial Agents and Chemotherapy, 1975
- The Hemostatic Defect Produced by CarbenicillinNew England Journal of Medicine, 1974
- The Metabolic Fate of α-Sulphobenzylpenicillin in RatsXenobiotica, 1972
- CARBENICILLIN-INDUCED BLEEDING DISORDERThe Lancet, 1970
- Carbenicillin in renal failure.1970
- The release of nucleotides, 5‐hydroxytryptamine and enzymes from human blood platelets during aggregationThe Journal of Physiology, 1968
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962